Novakand Pharma AB (publ) (LARK) — Free Cash Flow Generation Index

Latest as of September 2022: 1.00x

Novakand Pharma AB (publ) (LARK) has a Free Cash Flow Generation Index of 1.00x as of September 2022. Free cash flow of Skr379.00K represents 1% of operating cash flow (Skr379.00K). Read total liabilities of Novakand Pharma AB (publ) for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

Skr379.00K

SEK

Operating Cash Flow

Skr379.00K

SEK

Capital Expenditures

Skr0.00

SEK

Novakand Pharma AB (publ) Free Cash Flow Generation Index (2012–2021)

Historical FCF Generation Index trend for Novakand Pharma AB (publ) across 3 annual periods. Explore LARK capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Novakand Pharma AB (publ) (2012–2021)

Year-by-year Free Cash Flow Generation Index for Novakand Pharma AB (publ). For the full company profile including market capitalisation, see Novakand Pharma AB (publ) stock valuation.

Year	FCG Index	Free Cash Flow (SEK)	Operating CF	Capital Expenditures	YoY Change
2021	0.99x	Skr21.97 Million	Skr22.11 Million	Skr147.73K	▲ +211.6%
2018	-0.89x	Skr-202.60K	Skr227.60K	Skr430.20K	▼ -189.0%
2012	1.00x	Skr59.21K	Skr59.21K	Skr0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).